Acetylation of phenelzine

Area of Science:

• Pharmacology and Toxicology
• Biochemistry
• Drug Metabolism

Background:

• N-acetyltransferase (NAT) enzymes are crucial for drug metabolism.
• Phenelzine is an antidepressant known to be metabolized by acetylation.
• Understanding inter-individual variability in NAT activity is important for drug efficacy and safety.

Purpose of the Study:

• To investigate the presence and activity of N-acetyltransferase in liver preparations.
• To determine if liver microsome-free preparations can acetylate phenelzine in vitro.
• To correlate in vitro findings with in vivo patient data regarding phenelzine metabolism.

Main Methods:

• Utilized microsome-free rodent and human liver preparations.
• Assayed N-acetyltransferase activity using procainamide as a substrate.
• Quantified phenelzine acetylation using radiolabeled acetate transfer.
• Analyzed urine samples from 27 patients to measure phenelzine excretion and sulphadimidine acetylation.

Main Results:

• N-acetyltransferase activity was detected in microsome-free rodent and human liver preparations.
• These preparations demonstrated the ability to acetylate phenelzine in vitro.
• A negative correlation was observed between urinary phenelzine excretion and sulphadimidine acetylation in patients.

Conclusions:

• Microsome-free liver preparations effectively acetylate phenelzine, confirming its metabolism via N-acetyltransferase.
• The in vitro findings are supported by in vivo patient data, suggesting a link between acetylation capacity and phenelzine metabolism.
• This study provides evidence for phenelzine acetylation in human and rodent liver, contributing to the understanding of its pharmacokinetics.